Actively Recruiting
Investigating the Efficacy of a Paediatric Fertility Preservation Decision Aid in Parents and Adolescents and Young Adults (CAYA) Cancer Survivors
Led by Murdoch Childrens Research Institute · Updated on 2025-12-16
358
Participants Needed
1
Research Sites
29 weeks
Total Duration
On this page
Sponsors
M
Murdoch Childrens Research Institute
Lead Sponsor
U
University of Melbourne
Collaborating Sponsor
AI-Summary
What this Trial Is About
The current standard of care for paediatric patients with cancer regarding preservation of their fertility (FP) is to provide high-quality information during the clinical consultation process. However, this approach depends on health provider knowledge and communication and has been shown to be sub-optimal in some situations. This impairs the critical decision-making of patients regarding fertility testing, utilization of gametes, and continuing payment of storage fees. The fertility preservation decision aid (FP DA) may lead to a greater understanding of their fertility status for participants. This knowledge may allow participants the opportunity to assess potential fertility issues prior to the end of their reproductive window, helping to minimize missed opportunities for parenthood. This research study aims to assess the effectiveness of the use of the FP DA on unmet fertility information needs when it is provided in addition to high-quality information in parents of cancer survivors and CAYA cancer survivors compared to high-quality information alone.
CONDITIONS
Official Title
Investigating the Efficacy of a Paediatric Fertility Preservation Decision Aid in Parents and Adolescents and Young Adults (CAYA) Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to communicate in English
- Signed written informed consent form
- Parents/guardians of CAYA survivors who were 25 years or younger when diagnosed with cancer and have completed curative gonadotoxic treatment
- CAYA cancer survivors aged 16 years or older who have completed curative gonadotoxic treatment
- Participants may be on long-term adjuvant or endocrine therapy
- Participants may have had a pregnancy or livebirth
You will not qualify if you...
- CAYA patients currently undergoing cancer treatment and their parents/guardians
- CAYA patients who are palliative and their parents/guardians
- A family member already in the study
- Minors not deemed mature minors as per protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Murdoch Children's Research Institute
Melbourne, Victoria, Australia, 3052
Actively Recruiting
Research Team
D
Diana Navarro-Perez, PhD
CONTACT
Y
Yasmin Jayasinghe, FRANZCOG, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here